|Other Names||Inositol polyphosphate 1-phosphatase, IPP, IPPase, INPP1|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP8886c was selected from the Center region of human INPP1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Tissue Location||Ubiquitously expressed, with highest levels in pancreas and kidney|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
INPP1 is the enzyme inositol polyphosphate-1-phosphatase, one of the enzymes involved in phosphatidylinositol signaling pathways. This enzyme removes the phosphate group at position 1 of the inositol ring from the polyphosphates inositol 1,4-bisphosphate and inositol 1,3,4-trisphophosphate.
York,J.D., et.al., Proc. Natl. Acad. Sci. U.S.A. 90 (12), 5833-5837 (1993)Steen,V.M., et.al., Pharmacogenetics 8 (3), 259-268 (1998)
If you have any additional inquiries please email technical services at firstname.lastname@example.org.